instrument_fundamentals
| date | Close | change | Change (%) | instr__open | High | Low |
|---|
instr__news
Sartorius (OTCMKTS:SARTF) Sets New 1-Year High - Should You Buy? - Markets Daily
Sartorius (OTCMKTS:SARTF) Sets New 52-Week High - What's Next? - Stock Observer
Sartorius Group's Favorable Product Mix Drives Margin Expansion | Morningstar
Sartorius Stedim: Equipment Sales Remain Slow but Fundamentals Intact | Morningstar
Goldman Sachs Reaffirms Their Hold Rating on Sartorius (0NIR) | Markets Insider
Sartorius (0NIR) Receives a Hold from RBC Capital | Markets Insider
Sartorius Group Preliminary FY25 Profit Rises
Sartorius (OTCMKTS:SARTF) Shares Up 2.3% - Here's Why - Stock Observer
Sartorius (OTCMKTS:SARTF) Stock Price Up 2.3% - Should You Buy?
Sartorius' Expanded ISCC Plus Network Could Be A Game Changer For Sartorius (XTRA:SRT3)
Single-Use Bioprocessing Market Projected to Reach US$ 122.92 Billion by 2035, Supported by Expansion of Biomanufacturing Capacity Says Astute Analytica
How Sartorius' ISCC Plus Push Into Bio‑Circular Consumables At Sartorius (XTRA:SRT3) Has Changed Its Investment Story
Further production hubs in Germany and Tunisia now certified
$230.55 Bn Bioprocessing Global Market Trends, Opportunities and Strategies, 2019-2024, 2025-2029F, 2034F
Head-To-Head Comparison: Sartorius (OTCMKTS:SARTF) vs. Thermo Fisher Scientific (NYSE:TMO) - Stock Observer
